Truist Securities Maintains Hold on Agilon Health, Raises Price Target to $112
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Jailendra Singh maintains Agilon Health (NYSE:AGL) with a Hold and raises the price target from $67 to $112.
Truist Securities analyst Jailendra Singh maintains Agilon Health (NYSE:AGL) with a Hold and raises the price target from $67 to $112.